Skip to Content

Provenge (sipuleucel-T) Disease Interactions

There are 2 disease interactions with Provenge (sipuleucel-T):

Moderate

Sipuleucel-T (Includes Provenge) ↔ thromboembolism

Moderate Potential Hazard, Moderate plausibility. Applies to: Thrombotic/Thromboembolic Disorder

The use of sipuleucel-T can cause thromboembolism, including deep venous thrombosis and pulmonary embolism. It is recommended to exercise caution when using this agent in patients with risk factors for thromboembolic events. Close monitoring is recommended.

References

  1. "Product Information. Adagen (pegademase bovine)." Enzon Inc, Piscataway, NJ.
Moderate

Sipuleucel-T (Includes Provenge) ↔ vascular disorder

Moderate Potential Hazard, Moderate plausibility. Applies to: Myocardial Infarction, Cerebral Vascular Disorder

Vascular disorders that include, cerebrovascular and cardiovascular events have occurred with the use of sipuleucel-T. It is recommended to exercise caution when using this agent in patients with risk factors for vascular disorders such as, hemorrhagic and ischemic strokes, and myocardial infarctions. Close monitoring is recommended.

Provenge (sipuleucel-T) drug interactions

There are 208 drug interactions with Provenge (sipuleucel-T)

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide